Abstract | BACKGROUND: Currently, Liver cancer is the fifth most common tumor and the second most important reason for cancer-related death in the world. However, there are still many limitations of the clinical treatment of liver cancer, and new treatment options are clearly needed. Fortunately, studies have shown that L- Selenocysteine has a certain effect on cancer. This study was to investigate the effects of L- Selenocysteine on the inhibition of cell proliferation and the promotion of apoptosis of HepG-2 cells through ROS mediated fine signaling pathway. MATERIALS AND METHODS:
CCK-8 assay was applied to evaluating the cytotoxic effect of L- Selenocysteine on HepG-2 cells. Electron microscopy, flow cytometry and Western Blot was utilization in further researching cells signaling pathways. RESULTS: The growth of HepG-2 cells was inhibited by L- selenocysteine treatment in a dose-dependent manner. The cell viability decreased to 52.20%, 43.20% and 30.83% under the treatment of 4, 8, 16 µM L- selenocysteine, respectively. L- Selenocysteine had higher cytotoxicity towards HepG-2 cells than normal cells. L- Selenocysteine can induce the apoptosis of HepG-2 cells by increasing the DNA fragmentation, and activating the Caspase-3. In addition, it was found that the mechanism of the induction to HepG-2 cell apoptosis by L- Selenocysteine was closely related to the overproduction of ROS and promoted apoptosis through the Bcl-2 signaling pathway. CONCLUSIONS: Our data suggest that L- selenocysteine may cause mitochondrial damage and subsequently stimulate ROS production. ROS can damage cellular DNA and mediate the production of Casapase-8, Bid, Bcl-2 and other proteins, affecting downstream signaling pathways, and ultimately induced apoptosis.
|
Authors | Kaiying Zhang, Jingyao Su, Danyang Chen, Binger Lin, Yucan Wu, Yibing Wang, Jiapei Lei, Ruilin Zheng, Bing Zhu, Yinghua Li |
Journal | Molecular biology reports
(Mol Biol Rep)
Vol. 49
Issue 9
Pg. 8381-8390
(Sep 2022)
ISSN: 1573-4978 [Electronic] Netherlands |
PMID | 35716289
(Publication Type: Journal Article)
|
Copyright | © 2022. The Author(s), under exclusive licence to Springer Nature B.V. |
Chemical References |
- Proto-Oncogene Proteins c-bcl-2
- Reactive Oxygen Species
- Selenocysteine
|
Topics |
- Apoptosis
- Cell Line, Tumor
- Humans
- Liver Neoplasms
(metabolism)
- Membrane Potential, Mitochondrial
- Mitochondria
(metabolism)
- Proto-Oncogene Proteins c-bcl-2
(genetics)
- Reactive Oxygen Species
(metabolism)
- Selenocysteine
(metabolism, pharmacology, therapeutic use)
- Signal Transduction
|